Home Overview Press Room Blog Publications For Students about us
Search

Personal genomics : Displaying 229-248 of 899


Get Genetic Testing and Cheat the System?by Robert KlitzmanCNNMarch 13th, 2015Many people undergo genetic testing on their own and pay out of pocket, allowing them to keep the result to themselves.
23andMe Adds On: More About The Gene-Test Maker’s Drug R&D Ambitionsby Alex LashXconomyMarch 12th, 2015"We definitely think genetics should be married with all the other info being tracked. That will come in time."
23andMe to Use Genetic Database for Drug Discoveryby Ron WinslowWall Street JournalMarch 12th, 201523andMe's new therapeutics group, led by a star drug developer, will have "the opportunity to look broadly through the database and not have a particular restriction to what we’re looking for."
Privacy and the 100,000 Genome Projectby Edward Hockings and Lewis CoyneThe GuardianMarch 10th, 2015As the Department of Health starts to draw a map of thousands of genomes, will it keep its promise to anonymize our data?
Genetic Testing Ads Not Telling the Whole Story, Study Saysby Sabriya RiceModern HealthcareMarch 6th, 2015"There are very important limitations...but they are not widely reported on websites that market personalized cancer care."
Pregnant Women Are Finding Out They Have Cancer From A Genetic Test Of Their Babiesby Virginia HughesBuzzFeedMarch 5th, 2015When it comes to prenatal tests, it’s not clear whether incidental findings have clear-cut diagnostic value. And false positives might spur a pregnant woman to go through unnecessary medical procedures.
Supreme Court Gives Tacit Approval for Government to Take Anybody’s DNAby David KravetsArs TechnicaMarch 2nd, 2015The Supreme Court has let stand the conviction of a rapist whose prosecution rested on DNA swiped from the armrests of an interrogation-room chair.
23andMe’s Dangerous Business Modelby Marcy DarnovskyThe New York TimesMarch 2nd, 2015Handing over reams of our genetic, health and personal information to companies like 23andMe – and paying them for the privilege – is far from the only path to scientific advance.
Anne Wojcicki’s Quest to Put People in Charge of Their Own Health[Quotes CGS's Marcy Darnovsky]by Stephanie LeeSan Francisco ChronicleFebruary 28th, 201523andMe has attracted nearly a million customers and more than $126 million in venture capital, but not everyone thinks it should be the one to collect their data.
Building a Face, and a Case, on DNAby Andrew PollackThe New York TimesFebruary 23rd, 2015Rather than an artist’s rendering based on witness descriptions, the face was generated by a computer relying solely on DNA found at the scene of the crime.
The 23andMe Experience - A Lot of Knowledge is of Little Help?by Alison LashwoodBioNewsFebruary 23rd, 2015Those in favour see direct-to-consumer genetic tests as a way of engaging the public with science and making it fun, but there are problematic aspects, too.
US Regulators Try to Tame 'Wild West' of DNA Testingby Erika Check HaydenNature NewsFebruary 20th, 2015A particular sticking point is who decides what the genetic read-outs mean in terms of health and disease.
FDA Clearance of DTC Genetic Test Gets Mixed Reviewsby Ricki LewisMedscsape February 20th, 2015The FDA has authorized 23andMe to market a direct-to-consumer carrier test for Bloom syndrome.
Reading Our Genome is Tough, But Epigenetics is Giving Us Valuable Cluesby Marcus WooWiredFebruary 19th, 2015If the genome is a book, then the epigenome is like the post-it notes, dog-ears, and highlights that help you make sense of a particularly dense text.
Internet of DNAby Antonio RegaladoMIT Technology ReviewFebruary 19th, 2015A global network of millions of genomes could be medicine’s next great advance, but important challenges remain.
Precision Medicine Has Imprecise Ethics by Craig KlugmanBioethics.netFebruary 18th, 2015Will precision medicine increase or decrease health disparities? Will having a certain genetic subtype of a disease increase or decrease stigmatization of the disease?
Genes Tell Only Part of the Storyby Abigail ZugerThe New York TimesFebruary 16th, 2015Genes are seldom the whole story behind illness, and are possibly not even the sternest of the medical fates that control us.
Whole-Genome Sequencing Now Possible for IVFGenetic Engineering & Biotechnology NewsFebruary 12th, 2015Scientists have developed a whole-genome sequencing method that uses cell biopsies from in vitro embryos to scan for potentially detrimental mutations.
Big Data and Privacy Rightsby Xavier SymonsBioEdgeFebruary 7th, 2015A review of the British Government’s "care.data" scheme has found that the existing privacy framework needs major revision.
The Problem with Precision Medicineby Cynthia GraberThe New YorkerFebruary 5th, 2015As scientists continue to draw connections between DNA data and health outcomes, the problem of interpretability grows.
Displaying 229-248 of 899  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760